CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (6,752,000,000)	$ (4,688,000,000)	$ (1,018,000,000)
Depreciation and amortization	652,000,000	197,000,000	29,000,000
Stock-based compensation	987,000,000	570,000,000	0
Other expenses (Note 2)	0	643,000,000	0
Loss on convertible notes, net	0	441,000,000	0
Inventory write-downs and losses on firm purchase commitments	920,000,000	95,000,000	0
Other non-cash activities	82,000,000	36,000,000	41,000,000
Changes in operating assets and liabilities:
Accounts receivable	(76,000,000)	(20,000,000)	11,000,000
Inventory	(1,657,000,000)	(369,000,000)	0
Other current assets	(14,000,000)	(81,000,000)	(34,000,000)
Other non-current assets	(22,000,000)	(8,000,000)	(8,000,000)
Accounts payable and accrued liabilities	623,000,000	461,000,000	121,000,000
Other current liabilities	104,000,000	83,000,000	11,000,000
Other non-current liabilities	101,000,000	18,000,000	(1,000,000)
Net cash used in operating activities	(5,052,000,000)	(2,622,000,000)	(848,000,000)
Cash flows from investing activities:
Capital expenditures	(1,369,000,000)	(1,794,000,000)	(914,000,000)
Net cash used in investing activities	(1,369,000,000)	(1,794,000,000)	(914,000,000)
Cash flows from financing activities:
Proceeds from share issuance upon initial public offering, net of underwriting discounts and commissions and offering costs	0	13,530,000,000	0
Proceeds from issuance of capital stock including employee stock purchase plan	102,000,000	2,658,000,000	2,506,000,000
Proceeds from issuance of convertible notes	0	2,500,000,000	0
Proceeds from issuance of long-term debt, net of discount and debt issuance costs	0	1,226,000,000	0
Principal payments and other financing activities	(3,000,000)	(86,000,000)	(6,000,000)
Net cash provided by financing activities	99,000,000	19,828,000,000	2,500,000,000
Effect of exchange rate changes on cash and cash equivalents	(2,000,000)	0	0
Net change in cash	(6,324,000,000)	15,412,000,000	738,000,000
Cash, cash equivalents, and restricted cash—Beginning of period	18,423,000,000	3,011,000,000	2,273,000,000
Cash, cash equivalents, and restricted cash—End of period	12,099,000,000	18,423,000,000	3,011,000,000
Supplemental disclosure of cash flow information:
Cash paid for interest	88,000,000	2,000,000	4,000,000
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	364,000,000	479,000,000	325,000,000
Conversion of convertible notes	0	2,941,000,000	0
Conversion of convertible preferred stock	0	7,894,000,000	0
Warrants issuance	$ 0	$ 0	$ 3,000,000